Antibody Levels and Protection from Malaria in Ghanaian Children
Author Information
Author(s): Dodoo Daniel, Aikins Anastasia, Kusi Kwadwo Asamoah, Lamptey Helena, Remarque Ed, Milligan Paul, Bosomprah Samuel, Chilengi Roma, Osei Yaa Difie, Akanmori Bartholomew Dicky, Theisen Michael
Primary Institution: Noguchi Memorial Institute for Medical Research, University of Ghana
Hypothesis
This study aimed to assess the relationship between antibody responses to malaria vaccine candidate antigens and protection from clinical malaria in Ghanaian children.
Conclusion
The study confirmed that antibodies to MSP119 are important in reducing the risk of clinical malaria in Ghanaian children.
Supporting Evidence
- Higher levels of IgG to GLURP, MSP119, and MSP3 were associated with decreased malaria incidence.
- Only IgG1 to MSP119 was significantly associated with reduced incidence of clinical malaria after adjustments.
- The incidence rate of malaria was 0.35 episodes per child per year.
Takeaway
The more antibodies kids have against certain malaria proteins, the less likely they are to get sick from malaria.
Methodology
Standardized ELISA protocols were used to measure antibody levels in plasma samples from children, followed by nine months of malaria surveillance.
Potential Biases
Potential biases may arise from differences in malaria transmission intensity and the use of different study designs.
Limitations
The study was limited to a specific geographical area and may not be generalizable to other regions.
Participant Demographics
Children aged three to ten years from Dodowa, Ghana.
Statistical Information
P-Value
0.018
Confidence Interval
(0.67–0.97)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website